develop
safe
simpl
reliabl
screen
method
sar
diagnosi
epidemiolog
studi
two
recombin
sarscov
nucleocapsid
protein
n
protein
protein
express
escherichia
coli
purifi
affin
chromatographi
use
antigen
indirect
immunoglobulin
g
enzymelink
immunosorb
assay
elisa
serum
sampl
collect
healthi
volunt
sar
patient
vietnam
use
evalu
newli
develop
method
n
proteinbas
elisa
show
highli
nonspecif
reaction
proteinbas
elisa
nonspecif
reaction
drastic
reduc
compar
nearli
vietnam
screen
proteinbas
elisa
posit
sampl
confirm
viru
neutral
test
four
hcw
identifi
inappar
sarscov
infect
vietnam
indic
subclin
sarscov
infect
vietnam
rare
exist
sever
acut
respiratori
syndrom
sar
recent
emerg
human
diseas
associ
pneumonia
first
outbreak
recogn
late
februari
hanoi
vietnam
believ
origin
novemb
guangdong
provinc
china
sever
hundr
case
sever
atyp
pneumonia
follow
detect
similar
case
hong
kong
canada
world
health
organ
issu
global
alert
ill
later
design
sar
diseas
sinc
affect
countri
five
contin
case
death
identif
viru
subsequ
unravel
sar
coronaviru
cov
genom
sequenc
import
public
health
perspect
sarscov
genom
kb
size
compris
open
read
frame
contain
wellconserv
region
encod
rnadepend
rna
polymeras
two
open
read
frame
variabl
region
encod
four
viral
structur
protein
spike
protein
envelop
e
protein
membran
protein
nucleocapsid
n
protein
five
put
gene
encod
uncharacter
protein
gene
order
similar
known
coronavirus
howev
phylogenet
analys
sequenc
comparison
indic
viru
close
resembl
previous
character
coronavirus
epidemiolog
sar
remain
poorli
understood
still
unclear
whether
sarscov
asymptomat
infect
exist
inform
import
understand
virul
viru
pathogenesi
also
identifi
potenti
implic
transmiss
control
sar
exist
report
nonpneumon
subclin
sar
coronaviru
infect
conflict
one
hand
chan
et
al
chow
et
al
report
subclin
infect
found
among
health
care
worker
hcw
hand
woo
colleagu
suggest
report
nonpneumon
sarscov
infect
common
sar
pneumonia
therefor
clarifi
moreextens
seropreval
studi
need
current
wide
use
serolog
assay
sar
indirect
immunofluoresc
assay
use
sarscovinfect
cell
enzymelink
immunosorb
assay
elisa
use
cell
cultur
extract
antigen
addit
caus
antigen
crossreact
sarscovinfect
vero
cell
group
coronavirus
method
difficult
often
cumbersom
moreov
sarscovinfect
cell
cell
cultur
extract
present
consider
risk
infect
among
laboratori
worker
frequent
incid
sar
infect
among
laboratori
research
singapor
taiwan
beij
china
caus
great
concern
laboratori
safeti
henc
safer
conveni
method
sar
diagnosi
largescal
epidemiolog
studi
need
sar
outbreak
vietnam
began
admiss
travel
hong
kong
french
hospit
threestori
privat
own
expatriateoper
hospit
locat
hanoi
vietnam
februari
within
week
extens
nosocomi
transmiss
sar
occur
mainli
among
hospit
staff
march
hospit
close
new
admiss
except
hospit
worker
april
vietnam
becam
first
countri
recogn
contain
sar
outbreak
announc
vietnam
sar
occur
mainli
abovement
french
hospit
among
hcw
exist
clear
index
case
transmit
viru
close
contact
identifi
characterist
made
place
ideal
studi
epidemiolog
diseas
undertak
studi
sarscov
subclin
infect
among
vietnames
hcw
develop
truncat
sarscov
n
proteinbas
elisa
system
use
recombin
techniqu
new
elisa
system
safer
specif
sensit
diagnosi
sarscov
infect
present
studi
describ
exist
asymptomat
sarscov
infect
vietnam
proven
use
new
screen
method
confirm
viru
neutral
test
data
sensit
specif
sarscov
elisa
system
base
recombin
truncat
n
protein
discuss
serum
sampl
one
hundr
seventyf
serum
sampl
healthi
volunt
hanoi
collect
sar
outbreak
use
neg
control
serum
sampl
hcw
close
contact
sar
patient
french
hospit
hanoi
includ
studi
among
probabl
sar
case
per
case
definit
symptom
free
serial
serum
sampl
probabl
sar
case
symptomfre
hcw
collect
march
april
rna
extract
sarscov
strain
hanoi
isol
vietnames
patient
propag
vero
cell
line
maintain
eagl
minimum
essenti
medium
supplement
fetal
calf
serum
mm
nonessenti
amino
acid
day
upon
observ
cytopath
effect
cpe
infect
cultur
supernat
clarifi
light
centrifug
g
min
viral
rna
extract
l
infect
cultur
supernat
use
qiaamp
viral
rna
minikit
qiagen
hilden
germani
accord
manufactur
instruct
extract
rna
elut
l
elut
buffer
use
templat
revers
transcript
rt
pcr
construct
recombin
plasmid
gene
sarscov
n
protein
amplifi
rtpcr
previous
describ
pcr
amplif
carri
use
primer
gener
gene
protein
n
protein
four
lead
amino
acid
aa
clip
primer
gener
gene
protein
second
n
protein
construct
aa
n
terminu
truncat
sens
revers
primer
contain
bamhi
sali
restrict
site
underlin
respect
pcramplifi
dna
fragment
digest
bamhi
sali
subsequ
clone
correspond
restrict
site
vector
qiagen
hilden
germani
two
express
product
one
encompass
aa
anoth
encompass
aa
sarscov
n
protein
obtain
construct
contain
vectorderiv
tag
histidin
hexam
n
termini
result
recombin
protein
design
sar
sar
respect
express
purif
recombin
sarscov
n
protein
recombin
sarscov
n
protein
express
insert
recombin
plasmid
contain
sarscov
sarscov
sequenc
escherichia
coli
strain
cultur
luriabertani
medium
contain
gml
ampicillin
optic
densiti
nm
od
cultur
reach
express
recombin
protein
induc
addit
mm
iptg
h
cell
harvest
centrifug
wash
phosphatebuff
salin
pb
solut
resuspend
mm
pb
ph
mm
nacl
frozen
frozen
thaw
three
time
cell
suspens
sonic
min
interv
puls
centrifug
g
min
supernat
appli
talon
imac
resin
column
clontech
wash
mm
mm
nacl
contain
mm
imidazol
purifi
protein
elut
mm
pb
ph
mm
nacl
contain
mm
imidazol
protein
solut
aliquot
store
final
concentr
glycerol
use
protein
concentr
determin
bradford
method
protein
assay
reagent
kit
biorad
puriti
protein
analyz
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
western
blot
analysi
western
blot
perform
describ
towbin
et
al
briefli
protein
separ
polyacrylamid
gel
transfer
polyvinyliden
difluorid
pvdf
membran
immobilon
millipor
use
semidri
electroblott
sartoriu
germani
membran
initi
block
blockac
yukijirushi
sapporo
japan
overnight
subject
reaction
mous
antihistidin
serum
dilut
amersham
bioscienc
nj
sarscovimmun
rabbit
serum
dilut
suppli
nation
institut
infecti
diseas
japan
sar
patient
serum
dilut
h
incub
rabbit
antimous
immunoglobulin
g
igg
peroxidas
conjug
goat
antirabbit
iggperoxidas
conjug
goat
antihuman
iggperoxidas
conjug
dilut
conjug
procur
american
qualex
california
h
final
reaction
result
visual
dimethylamino
benzidin
dab
stain
elisa
use
recombin
nucleocapsid
protein
total
serum
sampl
collect
healthi
volunt
vietnam
sar
outbreak
serial
serum
sampl
collect
patient
pneumonia
use
assess
igg
antibodi
elisa
optim
concentr
recombin
protein
determin
checkerboard
titrat
differ
dilut
coat
recombin
protein
optim
amount
antigen
plate
coat
g
per
elisa
well
recombin
protein
ninetysixwel
nunc
immunopl
roskild
denmark
coat
recombin
protein
antigen
carbon
buffer
ph
overnight
block
blockac
h
room
temperatur
immunopl
wash
six
time
pbstween
l
human
serum
dilut
blockac
ad
well
incub
h
plate
wash
six
time
pbstween
l
horseradish
peroxidaseconjug
goat
antihuman
igg
american
qualex
california
ad
well
plate
incub
h
six
wash
pbstween
l
dilut
ophenylenediamin
ad
well
incub
dark
room
temperatur
min
reaction
stop
ad
l
n
h
well
od
well
measur
refer
filter
sampl
test
duplic
mean
od
sampl
calcul
elisa
titer
calcul
standard
reciproc
dilut
valu
use
thermolabsystem
ascent
photospectrometr
data
analysi
softwar
version
serum
sampl
check
twice
mean
antibodi
titer
record
elisa
use
sarscovinfect
cell
lysat
elisa
use
sarscovinfect
vero
cell
lysat
perform
accord
protocol
center
diseas
control
prevent
atlanta
georgia
cell
lysat
sarscovinfect
uninfect
vero
cell
suppli
center
diseas
control
prevent
viru
neutral
test
viru
neutral
test
done
biosafeti
level
condit
use
tissu
cultur
infect
dose
method
briefli
sera
heat
inactiv
min
serial
dilut
twofold
equal
volum
virusinfect
cell
cultur
fluid
titer
tissu
cultur
infect
dose
ad
l
serum
dilut
incub
h
dilut
ad
triplic
well
cultur
plate
vero
cell
previous
grown
confluenc
day
exist
cpe
determin
quantifi
neutral
titer
express
reciproc
valu
highest
dilut
serum
reduct
cpe
observ
express
purif
recombin
sarscov
n
protein
recombin
sarscov
n
protein
encompass
amino
acid
residu
nucleocapsid
protein
amplifi
rtpcr
clone
bamhi
sali
site
express
vector
frame
downstream
sixhistidin
tag
recombin
protein
success
express
e
coli
purifi
use
talon
metal
affin
column
natur
condit
analysi
purifi
recombin
protein
sdspage
coomassi
blue
stain
reveal
predict
singl
protein
band
kda
kda
two
recombin
sarscov
protein
respect
fig
ident
recombin
sarscov
protein
confirm
western
blot
assay
mous
antihistidin
serum
sarscovimmun
rabbit
serum
sar
patient
serum
fig
calibr
elisa
recombin
n
protein
order
determin
basal
titer
cutoff
valu
serum
sampl
collect
healthi
volunt
vietnam
sar
outbreak
use
assess
indirect
igg
elisa
recombin
sarscov
sarscov
protein
protein
use
coat
antigen
serum
sampl
show
titer
higher
rang
contrari
sarscov
protein
use
sampl
show
titer
analysi
posit
sampl
western
blot
also
confirm
reactiv
data
shown
indic
posit
reaction
elisa
due
potenti
interact
residu
e
coli
antigen
natur
occur
antibodi
e
coli
human
sera
chose
seven
serum
sampl
show
high
titer
proteinbas
elisa
neg
proteinbas
elisa
confirm
reactiv
western
blot
assay
shown
fig
seven
sampl
posit
proteinbas
western
blot
assay
neg
proteinbas
western
blot
assay
indic
western
blot
analysi
sera
react
protein
protein
purifi
recombin
protein
separ
sdspage
transfer
pvdf
membran
separ
membran
cut
strip
incub
dilut
serum
dilut
seven
healthi
volunt
ii
iii
iv
v
vi
vii
follow
horseradish
peroxidaseconjug
antihuman
igg
dilut
detect
dab
stain
sera
show
high
titer
antibodi
protein
proteinbas
elisa
neg
proteinbas
elisa
p
sar
patient
serum
use
posit
control
oddnumb
lane
repres
reaction
protein
evennumb
lane
repres
reaction
protein
posit
sampl
confirm
western
blot
assay
among
iggposit
patient
protein
igg
seroconvers
rate
within
day
week
week
onset
fever
respect
one
patient
detect
igg
antibodi
protein
patient
serum
sampl
collect
day
onset
diseas
henc
late
seroconvers
sarscov
posit
might
explan
lack
reaction
also
test
patient
serum
sampl
recombin
proteinbas
elisa
found
reaction
rang
titer
show
differ
obtain
proteinbas
elisa
data
shown
recombin
proteinbas
igg
elisa
highest
igg
titer
observ
group
healthi
volunt
lowest
igg
titer
observ
sar
patient
therefor
set
cutoff
titer
proteinbas
igg
elisa
cutoff
titer
set
clinic
specif
proteinbas
igg
elisa
comparison
recombin
proteinbas
elisa
sarscovinfect
cell
lysatebas
elisa
compar
recombin
proteinbas
elisa
sarscovinfect
cell
lysatebas
elisa
use
serial
serum
sampl
collect
probabl
sar
case
shown
tabl
recombin
proteinbas
elisa
show
seroconvers
rate
sarscovinfect
cell
lysatebas
elisa
highest
titer
detect
earliest
seroconvers
time
detect
onset
ill
day
day
proteinbas
elisa
sarscovinfect
cell
lysatebas
elisa
respect
sampl
posit
method
proteinbas
elisa
detect
seroconvers
earlier
sarscovinfect
cell
lysatebas
elisa
sampl
day
sampl
median
seroconvers
time
day
day
geometr
mean
titer
proteinbas
elisa
sarscovinfect
cell
lysatebas
elisa
respect
use
recombin
proteinbas
igg
elisa
screen
serum
sampl
collect
symptomfre
vietnames
hcw
close
contact
sar
patient
four
hcw
antisarscov
protein
antibodi
three
pair
sampl
test
show
igg
seroconvers
fourth
one
show
titer
singl
blood
serum
sampl
four
case
confirm
western
blot
neutral
test
neutral
antibodi
titer
observ
four
hcw
respect
three
individu
pair
serum
sampl
avail
first
serum
sampl
neg
neutral
test
clearli
demonstr
four
hcw
acquir
inappar
sarscov
infect
sar
outbreak
shown
tabl
hcw
close
contact
sar
patient
french
hospit
sar
experienc
asymptomat
infect
p
indic
exist
rel
low
rate
inappar
sarscov
infect
among
hcw
vietnam
sever
report
use
recombin
sarscov
nucleocapsid
protein
serodiagnosi
sarscov
clinic
infect
indic
sarscov
nucleocapsid
protein
highli
immunogen
abundantli
express
infect
therefor
use
diagnosi
sarscov
infect
sinc
n
protein
known
coronavirus
rel
conserv
import
ascertain
whether
sarscov
n
protein
crossreact
coronavirus
especi
antisera
human
coronavirus
sun
meng
report
n
protein
sarscov
react
strongli
polyclon
antisera
known
antigen
group
coronavirus
indic
sarscov
n
protein
share
common
antigen
epitop
recent
report
woo
et
al
found
convalescentphas
serum
sampl
person
infect
human
coronaviru
hcov
respect
test
posit
recombin
sarscov
nucleocapsid
proteinbas
elisa
suggest
crossreact
sarscov
n
protein
n
protein
report
antibodi
human
coronavirus
widespread
within
human
popul
recombin
sarscov
proteinbas
elisa
reveal
serum
sampl
healthi
volunt
collect
sar
outbreak
titer
higher
rang
taken
togeth
fact
indic
reactiv
observ
healthi
volunt
sera
present
studi
probabl
due
crossreact
exist
antibodi
circul
coronavirus
clearli
indic
care
taken
interpret
assay
result
fulllength
recombin
n
protein
sarscov
wholeviru
antigen
extract
virusinfect
cell
use
reagent
diagnosi
sarscov
infect
human
anim
speci
predict
n
protein
sarscov
highli
charg
basic
protein
amino
acid
seven
success
hydrophob
residu
near
middl
protein
although
overal
amino
acid
sequenc
homolog
sarscov
n
protein
human
coronavirus
low
sarscov
human
coronaviru
sarscov
human
coronaviru
highli
conserv
motif
fyylgtgp
occur
ntermin
half
coronaviru
n
protein
conserv
residu
report
occur
near
highli
conserv
motif
use
synthet
peptid
wang
et
al
found
immunoreact
epitop
site
sar
coronaviru
n
protein
locat
cooh
terminu
theori
find
made
possibl
remov
n
terminu
sarscov
n
protein
contain
conserv
motif
coronaviru
n
protein
reduc
crossreact
sar
diagnosi
express
truncat
sarscov
protein
highli
conserv
motif
fyylgtgp
delet
protein
use
coat
antigen
elisa
sampl
show
weak
reaction
titer
rang
much
fewer
posit
sampl
titer
much
lower
observ
protein
use
confirm
western
blot
analysi
fig
result
support
fact
sarscov
n
protein
show
crossreact
coronavirus
crossreact
caus
conserv
motif
present
within
n
terminu
protein
fact
sampl
also
show
although
low
titer
reactiv
sarscov
protein
suggest
minor
common
motif
might
still
exist
within
truncat
protein
final
solv
crossreact
problem
set
cutoff
titer
weak
reaction
interpret
neg
elisa
system
assess
sensit
proteinbas
igg
elisa
serial
collect
serum
sampl
probabl
sar
case
examin
thirtysix
patient
show
igg
seroconvers
serum
titer
rang
among
posit
case
protein
igg
seroconvers
rate
onset
ill
first
week
second
week
third
week
recombin
proteinbas
elisa
sensit
could
detect
seroconvers
earlier
virusinfect
cell
lysatebas
elisa
system
tabl
newli
develop
sarscov
proteinbas
igg
elisa
safe
specif
sensit
test
diagnosi
sarscov
infect
therefor
may
use
clinic
diagnosi
largescal
seroepidemiolog
studi
use
sarscov
proteinbas
igg
elisa
screen
serum
sampl
symptomfre
hcw
direct
contact
sar
patient
vietnam
found
four
symptomfre
hcw
develop
antibodi
sarscov
addit
posit
reaction
confirm
western
blot
viru
neutral
test
prove
four
symptomfre
hcw
truli
subclin
sarscov
infect
comparison
rate
symptomat
asymptomat
sarscov
infect
among
hcw
vietnam
reveal
symptomat
infect
common
subclin
infect
tabl
therefor
data
strongli
indic
subclin
sarscov
infect
actual
exist
although
quit
low
rate
vietnam
first
countri
sar
acknowledg
begin
outbreak
sever
diseas
recogn
henc
effect
prevent
measur
taken
therefor
within
week
extens
nosocomi
transmiss
occur
among
hospit
staff
french
hospit
contacttrac
data
reveal
four
symptomfre
hcw
studi
antibodi
sarscov
direct
contact
index
case
howev
develop
sar
experienc
subclin
infect
proven
seroconvers
sever
report
deal
subclin
atyp
form
sar
lee
et
al
report
case
possibl
asymptomat
sarscov
infect
hong
kong
li
et
al
report
among
peopl
expos
sar
patient
develop
sar
nonpneumon
infect
addit
ho
et
al
report
hcw
teach
hospit
singapor
posit
sarscov
antibodi
among
six
probabl
suspect
sar
case
howev
two
fever
indic
small
number
mildli
symptomat
individu
exist
although
asymptomat
individu
found
chow
et
al
report
dot
blot
elisa
combin
viru
neutral
test
hcw
serum
sampl
subclin
sar
found
addit
chan
et
al
use
indirect
immunofluoresc
assay
examin
hcw
hospit
sar
outbreak
occur
none
hcw
antibodi
sarscov
later
report
ip
et
al
found
hcw
work
sar
medic
ward
subclin
infect
studi
use
inactiv
virusinfect
cell
extractbas
elisa
virusinfect
cellbas
immunofluoresc
assay
diagnosi
howev
shown
studi
inactiv
virusinfect
cell
extractbas
elisa
detect
sar
antibodi
low
sensit
besid
method
possibl
crossreact
human
coronavirus
exist
contrari
detect
system
consist
truncat
n
proteinbas
elisa
screen
symptomfre
hcw
confirm
viru
neutral
test
sensit
specif
give
much
reliabl
result
elucid
subclin
sarscov
infect
hand
woo
colleagu
use
recombin
n
proteinbas
elisa
combin
western
blot
analysi
detect
sarscov
n
protein
found
healthi
blood
donor
nonpneumon
inpati
posit
sarscov
antibodi
therefor
conclud
subclin
nonpneumon
sarscov
infect
common
sar
pneumonia
suspect
research
could
due
crossreact
misinterpret
result
consid
previous
report
inform
data
clear
subclin
mild
form
sarscov
infect
rare
exist
may
reason
control
measur
quarantin
patient
work
effect
contain
outbreak
vietnam
sarscov
newli
emerg
viru
human
immun
result
peopl
infect
develop
clinic
symptomat
infect
impli
anoth
outbreak
could
occur
peopl
may
acquir
immun
subclin
infect
henc
major
popul
might
remain
suscept
diseas
conclus
develop
sarscov
proteinbas
igg
elisa
safe
specif
sensit
test
diagnosi
sarscov
infect
also
demonstr
subclin
sarscov
infect
though
rare
inde
occur
